Hans Bloemendal was affiliated with Radboud University in the Netherlands during their research career.
The main fields of study addressed by Bloemendal included Medicine, with specific focus on the following subfields:
Bloemendal's research topics covered several key areas, including:
A notable recent publication by Bloemendal was titled "Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial", published in 2024 in Annals of Oncology.
Frequent coauthors in Bloemendal's work included:
Bloemendal published in venues such as:
Hans Bloemendal;Wilfried de Jong;Rainer Jaenicke;Rainer Jaenicke;Nicolette H. Lubsen
Hans Bloemendal
Patricia J. T. A. Groenen;Karin B. Merck;Wilfried W. De Jong;Hans Bloemendal
Frans J. Van Der Ouderaa;Wilfried W. De Jong;Ans Hilderink;Hans Bloemendal
Wilfried W. de Jong;Wiljan Hendriks;John W.M. Mulders;Hans Bloemendal
F.C.S. Ramaekers;M. Osborn;E. Schmid;K. Weber
Wim Quax;Wilma Vree Egberts;Wiljan Hendriks;Yvonne Quax-Jeuken
C. E. M. Voorter;W. A. De Haard-Hoekman;P. J. M. Van Den Oetelaar;H. Bloemendal
H. Bloemendal;Anneke Zweers;F. Vermorken;I. Dunia
Claudia S Alge;Siegfried G Priglinger;Aljoscha S Neubauer;Anselm Kampik
Voorter;John W. M. Mulders;Hans Bloemendal;Wilfried W. De Jong
H. Bloemendal;W. S. Bont;M. De Vries;E. L. Benedetti
Huub P. C. Driessen;Paul Herbrink;Hans Bloemendal;Wilfricd W. de Jong
Guy A. M. Berbers;Willeke A. Hoekman;Hans Bloemendal;Wilfried W. de Jong
R.H.P.H. Smulders;J.A. Carver;R.A. Lindner;M.A.M. van Boekel
Karin B. Merck;Willeke A. De Haard-Hoekman;Belinda B. Oude Essink;Hans Bloemendal
Yvonne E. F. M. Quax-Jeuken;Wim J. Quax;Hans Bloemendal
H J Dodemont;P Soriano;W J Quax;F Ramaekers
Claudia Vennegoor;Hans Bloemendal
Bloemendal H;de Jong Ww
If you think any of the details on this page are incorrect, let us know.